EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in early screening and diagnosis of sepsis: a narrative review

Xiao-Lian Zhou, Xiao-Bo Hu, Lu-Ying Shu, Yong-Sheng Wang

Frontiers in Cellular and Infection Microbiology · 01.07.2026 · 16

DOI: 10.3389/fcimb.2026.1864446 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 01.07.2026. Verfasst von Xiao-Lian Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second P…. Hauptthemen laut MEDLINE: Sepsis, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Characterized by acute onset, rapid progression and high mortality, it poses a major global public health challenge in critical care medicine. Early accurate screening and diagnosis are crucial to improving patient prognosis and reducing mortality. In recent years, with the rapid advancement of medical technology, early screening and diagnostic strategies for sepsis have been continuously updated. Diagnostic approaches have evolved from traditional clinical scoring systems such as the The Sequential Organ Failure Assessment (SOFA) score and routine inflammatory biomarker detection to novel biomarkers including soluble Triggering Receptor Expressed on Myeloid cells-1(sTREM-1) and soluble cluster of differentiation 14 subtype (presepsin), as well as intelligent diagnostic techniques represented by Sepsis ImmunoScore and machine learning algorithms. Based on recent domestic and international research evidence, this narrative review summarizes the latest advances in early screening and diagnosis of sepsis, analyzes the strengths and limitations of various modalities, and provides references for early clinical identification and precise diagnosis of sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisMass ScreeningHumansEarly DiagnosisBiomarkersTriggering Receptor Expressed on Myeloid Cells-1Lipopolysaccharide ReceptorsOrgan Dysfunction ScoresPeptide Fragments

Stichwörter der Autor:innen

biomarkersearly diagnosisearly screeningintelligent diagnosisresearch progresssepsis

Substanzen

BiomarkersTriggering Receptor Expressed on Myeloid Cells-1Lipopolysaccharide ReceptorsTREM1 protein, humanpresepsin protein, humanPeptide Fragments

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu Second People's Hospital, Chengdu, Sichuan,…
  • Department of Respiratory and Critical Care Medicine, Chongzhou People's Hospital, Chengdu, Sichuan, China.

Zitieren

APA

Zhou, X. L., Hu, X. B., Shu, L. Y., & Wang, Y. S. (2026). Recent advances in early screening and diagnosis of sepsis: a narrative review. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1864446

Vancouver

Zhou XL, Hu XB, Shu LY, Wang YS. Recent advances in early screening and diagnosis of sepsis: a narrative review. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1864446

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiao-Lian and Hu, Xiao-Bo and Shu, Lu-Ying and Wang, Yong-Sheng},
  title = {Recent advances in early screening and diagnosis of sepsis: a narrative review},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1864446}
}
Kostenlos starten →